BRIEF published on 11/10/2025 at 13:17, 24 days 18 hours ago Schloss Wachenheim AG : Perspectives positives et objectif de cours relevé Schloss Wachenheim AG Résultats Du T1 2025/26 Relèvement De L'objectif De Prix Reprise Du Segment Français Impacts Sur Le Rendement Des Obligations
BRIEF published on 11/10/2025 at 13:17, 24 days 18 hours ago Schloss Wachenheim AG: Positive Outlook with Increased Price Target Schloss Wachenheim AG Price Target Increase Q1 2025/26 Results France Segment Recovery Bond Yield Impacts
PRESS RELEASE published on 11/10/2025 at 13:12, 24 days 18 hours ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research upgrades Schloss Wachenheim AG, recommends Buy with target price of €20 after strong Q1 25/26 results. Sales up 3.5% to €106.0m First Berlin Equity Research Buy Recommendation Schloss Wachenheim AG Q1 25/26 Results €20 Target Price
BRIEF published on 09/30/2025 at 11:03, 2 months 4 days ago Schloss Wachenheim AG: Buy Rating Reiterated Despite Challenges Financial Results Buy Recommendation Sales Growth Schloss Wachenheim Market Forecast
BRIEF published on 09/30/2025 at 11:03, 2 months 4 days ago Schloss Wachenheim AG : recommandation d'achat réitérée malgré les difficultés Résultats Financiers Croissance Des Ventes Recommandation D'achat Prévisions Du Marché Château De Wachenheim
PRESS RELEASE published on 09/30/2025 at 10:58, 2 months 4 days ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Schloss Wachenheim AG analysis post-2024/25 Annual report, maintains BUY rating, lowers price target to €19 First Berlin Equity Research BUY Rating Analysis Price Target Schloss Wachenheim AG
BRIEF published on 05/12/2025 at 13:11, 6 months 23 days ago Schloss Wachenheim AG : baisse des ventes, mais optimisme pour le quatrième trimestre Performance Financière Recommandation D'achat Baisse Des Ventes Château De Wachenheim AG Rebond Au Quatrième Trimestre
BRIEF published on 05/12/2025 at 13:11, 6 months 23 days ago Schloss Wachenheim AG: Sales Decline but Optimism for Q4 Financial Performance Buy Recommendation Sales Decline Schloss Wachenheim AG Q4 Rebound
PRESS RELEASE published on 05/12/2025 at 13:06, 6 months 23 days ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research GmbH releases a research update on Schloss Wachenheim AG, maintaining a Buy recommendation with a lowered price target of €21 from €22 First Berlin Equity Research Buy Recommendation Price Target Schloss Wachenheim AG Q3 24/25 Results
BRIEF published on 02/24/2025 at 14:56, 9 months 8 days ago Schloss Wachenheim AG Sees Strong EBIT Growth Amid Lower Energy Costs Schloss Wachenheim AG EBIT Growth Market Forecast Sales Performance Energy Costs
Published on 12/05/2025 at 02:35, 4 hours 47 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 22 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 17 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 22 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 22 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 52 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 31 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 57 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 7 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 7 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 22 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 22 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 37 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 37 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
